DK2421808T3 - 4-Hydroxysmørsyreanaloger - Google Patents
4-HydroxysmørsyreanalogerInfo
- Publication number
- DK2421808T3 DK2421808T3 DK10716196.0T DK10716196T DK2421808T3 DK 2421808 T3 DK2421808 T3 DK 2421808T3 DK 10716196 T DK10716196 T DK 10716196T DK 2421808 T3 DK2421808 T3 DK 2421808T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxybutyric acid
- acid analogues
- analogues
- hydroxybutyric
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21438209P | 2009-04-23 | 2009-04-23 | |
| US28756109P | 2009-12-17 | 2009-12-17 | |
| PCT/US2010/031981 WO2010124046A1 (en) | 2009-04-23 | 2010-04-22 | 4-hydroxybutyric acid analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2421808T3 true DK2421808T3 (da) | 2013-11-04 |
Family
ID=42313221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10716196.0T DK2421808T3 (da) | 2009-04-23 | 2010-04-22 | 4-Hydroxysmørsyreanaloger |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US8461197B2 (da) |
| EP (1) | EP2421808B1 (da) |
| AU (1) | AU2010239244B2 (da) |
| CA (1) | CA2759251C (da) |
| DK (1) | DK2421808T3 (da) |
| ES (1) | ES2433242T3 (da) |
| HK (1) | HK1167641A1 (da) |
| HR (1) | HRP20131027T1 (da) |
| SI (1) | SI2421808T1 (da) |
| WO (1) | WO2010124046A1 (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010124046A1 (en) * | 2009-04-23 | 2010-10-28 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
| US9084467B2 (en) | 2010-02-11 | 2015-07-21 | Metabolix, Inc. | Process for gamma-butyrolactone production |
| WO2011119839A1 (en) | 2010-03-24 | 2011-09-29 | Jazz Pharmaceuticals, Inc. | Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
| CA2732479A1 (en) * | 2011-02-14 | 2012-08-14 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
| WO2012112492A1 (en) * | 2011-02-14 | 2012-08-23 | Concert Pharmaceuticals Inc. | 4-hydroxybutyric acid deuterated analogs |
| EP2888222A1 (en) * | 2012-08-22 | 2015-07-01 | Concert Pharmaceuticals Inc. | Deuterated 4-hydroxybutyric acid analogs |
| ES2774932T3 (es) | 2012-11-14 | 2020-07-23 | Cj Cheiljedang Corp | Producción de sales de 4-hidroxibutirato utilizando materias primas de base biológica |
| WO2014127053A2 (en) | 2013-02-13 | 2014-08-21 | Metabolix, Inc. | Process for ultra pure chemical production from biobased raw starting materials |
| ITMI20132041A1 (it) * | 2013-12-06 | 2015-06-07 | Ct Lab Farm Srl | Derivati dell'acido gamma-idrossibutirrico, loro preparazione e loro uso medico. |
| US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
| CN108283000B (zh) * | 2015-09-23 | 2021-04-13 | 凯瑞康宁生物工程（武汉）有限公司 | γ-羟基丁酸的前药及其组合物和用途 |
| US11000498B2 (en) | 2016-07-22 | 2021-05-11 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
| EP3601235A4 (en) | 2017-03-30 | 2020-11-18 | XW Laboratories Inc. | BICYCLIC HETERARYL DERIVATIVES, PREPARATION AND ASSOCIATED USES |
| US20200114015A1 (en) * | 2017-04-11 | 2020-04-16 | John K. Thottathil | Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other GRAS- Based Prodrugs Of Gamma-Hydroxybutyrate (GHB) And Uses Thereof |
| JP6996029B2 (ja) | 2018-09-30 | 2022-01-17 | エックスダブリューファルマ リミテッド | ニューロンヒスタミン受容体－３アンタゴニストとしての化合物およびその使用 |
| EP3883549A1 (en) | 2018-11-19 | 2021-09-29 | Jazz Pharmaceuticals Ireland Limited | Alcohol-resistant drug formulations |
| JP2022522270A (ja) | 2019-03-01 | 2022-04-15 | フラメル アイルランド リミテッド | 食事摂取状態における改善された薬物動態を有するガンマ－ヒドロキシ酪酸塩組成物 |
| CN115244028A (zh) | 2019-12-20 | 2022-10-25 | 凯瑞康宁生物工程有限公司 | 4-缬氨酰氧基丁酸的合成方法 |
| EP4167971A1 (en) | 2020-06-18 | 2023-04-26 | XWPharma Ltd. | Controlled release granulations of water-soluble active pharmaceutical ingredients |
| CN115803017A (zh) | 2020-06-18 | 2023-03-14 | 凯瑞康宁生物工程有限公司 | 水溶性活性药物成分的药物造粒物 |
| WO2022020621A1 (en) | 2020-07-24 | 2022-01-27 | XWPharma Ltd. | Pharmaceutical compositions and pharmacokinetics of a gamma-hydroxybutyric acid derivative |
| JP2023544420A (ja) | 2020-10-05 | 2023-10-23 | エックスダブリューファーマ リミテッド | ガンマ－ヒドロキシ酪酸誘導体の調節放出組成物 |
| AU2022238423A1 (en) | 2021-03-19 | 2023-10-19 | XWPharma Ltd. | Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric acid derivative |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0044801B1 (de) | 1980-07-17 | 1984-02-15 | Josef Dr. Klosa | Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel |
| ZA814854B (en) | 1980-07-17 | 1982-07-28 | J Klosa | Nonhygroscopic salts of 4-hydroxybutryric acid, methods of their production and pharmaceutical preparations containing these salts |
| US4548716A (en) | 1984-07-25 | 1985-10-22 | Lucas Boeve | Method of producing ultrapure, pyrogen-free water |
| US4738985A (en) | 1986-03-19 | 1988-04-19 | The University Of Toronto Innovations Foundations | Pharmaceutical composition and treatment |
| JP2727008B2 (ja) | 1989-02-01 | 1998-03-11 | 日本酸素株式会社 | 静菌化水の製造方法 |
| DE4113984C2 (de) | 1991-04-29 | 2002-05-08 | Koehler Chemie Dr Franz | Salze der 4-Hydroxy-Buttersäure |
| IT1248588B (it) | 1991-06-28 | 1995-01-19 | Gaetano Crepaldi | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. |
| US6221335B1 (en) | 1994-03-25 | 2001-04-24 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| WO1995026325A2 (en) | 1994-03-25 | 1995-10-05 | Isotechnika Inc. | Enhancement of the efficacy of drugs by deuteration |
| US5840331A (en) | 1995-06-07 | 1998-11-24 | Arch Development Corporation | Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin |
| DK2283834T3 (da) | 1997-03-17 | 2016-08-15 | Btg Int Ltd | Terapeutiske sammensætninger omfattende ketonforbindelser og forstadier deraf |
| US5990162A (en) | 1997-08-29 | 1999-11-23 | Orphan Medical, Inc. | Method for treatment of fibromyalgia and chronic fatigue syndrome |
| US6440710B1 (en) | 1998-12-10 | 2002-08-27 | The Scripps Research Institute | Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds |
| CA2383011C (en) | 1999-09-14 | 2008-07-22 | Tepha, Inc. | Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| US6204245B1 (en) | 1999-09-17 | 2001-03-20 | The Regents Of The University Of California | Treatment of narcolepsy with immunosuppressants |
| DE60001623T2 (de) | 1999-12-03 | 2003-12-18 | Pfizer Products Inc., Groton | Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel |
| ES2383673T3 (es) | 2000-09-22 | 2012-06-25 | Jpi Commercial, Llc | Composiciones de gamma-hidroxibutirato que contienen portadores de hidrato de carbonos |
| US7727549B2 (en) | 2002-07-15 | 2010-06-01 | Alcon, Inc. | Pharmaceutical compositions for otic use |
| TW200413273A (en) | 2002-11-15 | 2004-08-01 | Wako Pure Chem Ind Ltd | Heavy hydrogenation method of heterocyclic rings |
| US7598273B2 (en) | 2005-10-06 | 2009-10-06 | Auspex Pharmaceuticals, Inc | Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties |
| US7750168B2 (en) | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
| JO2630B1 (en) | 2006-04-13 | 2012-06-17 | نوفارتيس ايه جي | Organic compounds |
| CA2661404A1 (en) | 2006-09-05 | 2008-03-13 | Schering Corporation | Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
| US20090082380A1 (en) | 2007-09-25 | 2009-03-26 | Protia, Llc | Deuterium-enriched rosuvastatin |
| WO2010042759A2 (en) | 2008-10-08 | 2010-04-15 | Kyphia Pharmaceuticals Inc | Gaba conjugates and methods of use thereof |
| WO2010124046A1 (en) | 2009-04-23 | 2010-10-28 | Concert Pharmaceuticals, Inc. | 4-hydroxybutyric acid analogs |
| WO2012112492A1 (en) | 2011-02-14 | 2012-08-23 | Concert Pharmaceuticals Inc. | 4-hydroxybutyric acid deuterated analogs |
-
2010
- 2010-04-22 WO PCT/US2010/031981 patent/WO2010124046A1/en active Application Filing
- 2010-04-22 SI SI201030418T patent/SI2421808T1/sl unknown
- 2010-04-22 DK DK10716196.0T patent/DK2421808T3/da active
- 2010-04-22 ES ES10716196T patent/ES2433242T3/es active Active
- 2010-04-22 US US13/265,609 patent/US8461197B2/en active Active
- 2010-04-22 CA CA2759251A patent/CA2759251C/en active Active
- 2010-04-22 AU AU2010239244A patent/AU2010239244B2/en active Active
- 2010-04-22 EP EP10716196.0A patent/EP2421808B1/en active Active
-
2012
- 2012-08-23 HK HK12108273.7A patent/HK1167641A1/xx unknown
-
2013
- 2013-06-10 US US13/914,127 patent/US9051261B2/en not_active Expired - Fee Related
- 2013-10-30 HR HRP20131027AT patent/HRP20131027T1/hr unknown
-
2015
- 2015-06-08 US US14/732,859 patent/US9815763B2/en active Active
-
2017
- 2017-11-13 US US15/810,526 patent/US10532971B2/en active Active
-
2020
- 2020-01-10 US US16/739,422 patent/US11161798B2/en active Active
-
2021
- 2021-10-29 US US17/514,416 patent/US11939285B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US8461197B2 (en) | 2013-06-11 |
| US9815763B2 (en) | 2017-11-14 |
| US20120122952A1 (en) | 2012-05-17 |
| HRP20131027T1 (hr) | 2013-12-06 |
| EP2421808A1 (en) | 2012-02-29 |
| US9051261B2 (en) | 2015-06-09 |
| HK1167641A1 (en) | 2012-12-07 |
| ES2433242T3 (es) | 2013-12-10 |
| US10532971B2 (en) | 2020-01-14 |
| AU2010239244A1 (en) | 2011-11-10 |
| CA2759251C (en) | 2017-01-03 |
| US11939285B2 (en) | 2024-03-26 |
| US20220162146A1 (en) | 2022-05-26 |
| SI2421808T1 (sl) | 2013-12-31 |
| US20180155266A1 (en) | 2018-06-07 |
| US11161798B2 (en) | 2021-11-02 |
| US20200385330A1 (en) | 2020-12-10 |
| EP2421808B1 (en) | 2013-07-31 |
| US20140142179A1 (en) | 2014-05-22 |
| US20150344398A1 (en) | 2015-12-03 |
| AU2010239244B2 (en) | 2014-02-27 |
| CA2759251A1 (en) | 2010-10-28 |
| WO2010124046A1 (en) | 2010-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2421808T3 (da) | 4-Hydroxysmørsyreanaloger | |
| DK2361256T3 (da) | Cyclohexenyl-nukleinsyreanaloger | |
| CY2017026I1 (el) | Τετρακυκλικη ενωση | |
| BRPI1009192A2 (pt) | preparação de ácido adípico | |
| SMT201500053B (it) | 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori | |
| DK2398483T3 (da) | Oxyntomodulinanaloge | |
| BRPI1011650A2 (pt) | composições sólidas compreendendo ácido 5-aminolevulínico | |
| DK2623507T3 (da) | Morpholinonukleinsyrederivat | |
| BRPI1013937A2 (pt) | compostos de ácido carboxílico | |
| DK2480218T3 (da) | Syreresistente kapsler | |
| BRPI0919447A2 (pt) | derivados do ácido 1-amino-2-ciclobutiletilborônico | |
| DK2562155T3 (da) | Hydroxaminsyrederivat | |
| DK3266463T3 (da) | Hæmoglobinsammensætninger | |
| BRPI1013868A2 (pt) | composto diaciletilenodiamina | |
| DK2332510T3 (da) | Forbindelsesorgan | |
| DK2234994T3 (da) | Fedtsyre-butylester-blandinger | |
| DK2260053T3 (da) | Oxytocin-analoger | |
| BRPI0921038A2 (pt) | ácido naftilacéticos | |
| BRPI0914939A2 (pt) | tintas ácidas | |
| BR112012004300A2 (pt) | preparação de ácido acético. | |
| DK2451354T3 (da) | Lancet | |
| BR112012028007A2 (pt) | composição aquosa | |
| DOP2011000348A (es) | Construcciones casb7439 | |
| FR2952847B3 (fr) | > | |
| ES1070429Y (es) | Traspaleta mejorada |